Korean Drug Co. Ltd (KQ:014570) — Market Cap & Net Worth

$24.94 Million USD · ₩36.81 Billion KRW · Rank #24478

Market Cap & Net Worth: Korean Drug Co. Ltd (014570)

Korean Drug Co. Ltd (KQ:014570) has a market capitalization of $24.94 Million (₩36.81 Billion) as of September 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24478 globally and #1752 in its home market, demonstrating a -1.59% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Korean Drug Co. Ltd's stock price ₩3400.00 by its total outstanding shares 10825992 (10.83 Million). Also see Korean Drug Co. Ltd total assets for a full breakdown of the balance sheet.

Korean Drug Co. Ltd Market Cap History: 2015 to 2026

Korean Drug Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $31.54 Million to $24.94 Million (-2.34% CAGR). Also see Korean Drug Co. Ltd (014570) cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Korean Drug Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$234.31 Billion	0.01%	#912 of 1384
Kosdaq Composite Index KQ11	$234.31 Billion	0.01%	#912 of 1384

Weight: Korean Drug Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Korean Drug Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Korean Drug Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Korean Drug Co. Ltd stock quote for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

Korean Drug Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 1.32x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.00x

Korean Drug Co. Ltd's market cap is 0.00 times its annual earnings

Industry average: 11.81x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$42.44 Million	$55.31 Billion	$5.05 Billion	0.00x	0.01x
2017	$46.24 Million	$55.40 Billion	$4.68 Billion	0.00x	0.01x
2018	$48.06 Million	$52.03 Billion	$6.56 Billion	0.00x	0.01x
2019	$48.58 Million	$55.53 Billion	$3.90 Billion	0.00x	0.01x
2020	$70.63 Million	$66.79 Billion	$7.36 Billion	0.00x	0.01x
2021	$62.43 Million	$74.47 Billion	$9.04 Billion	0.00x	0.01x
2022	$55.99 Million	$79.98 Billion	$11.81 Billion	0.00x	0.00x
2023	$52.68 Million	$81.37 Billion	-$4.92 Billion	0.00x	N/A
2024	$33.71 Million	$73.00 Billion	$3.00 Billion	0.00x	0.01x
2025	$31.55 Million	$62.51 Billion	$6.51 Billion	0.00x	0.00x

Competitor Companies of 014570 by Market Capitalization

Companies near Korean Drug Co. Ltd in the global market cap rankings as of September 19, 2026. Review Korean Drug Co. Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Korean Drug Co. Ltd by market ranking:

Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $1.03 Trillion USD.
Eli Lilly and Company (SA:LILY34): Ranked #19 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
AbbVie Inc (NYSE:ABBV): Ranked #44 globally with a market cap of $356.49 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#15	Eli Lilly and Company	NYSE:LLY	$1.03 Trillion	$1152.44
#19	Eli Lilly and Company	SA:LILY34	$853.51 Billion	R$153.70
#29	Johnson & Johnson	NYSE:JNJ	$574.95 Billion	$270.22
#44	AbbVie Inc	NYSE:ABBV	$356.49 Billion	$264.02

Korean Drug Co. Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Korean Drug Co. Ltd's market cap moved from $31.54 Million to $ 24.94 Million, with a yearly change of -2.34%.

Year	Market Cap	Change (%)
2026	₩24.94 Million	-20.93%
2025	₩31.55 Million	-6.42%
2024	₩33.71 Million	-36.00%
2023	₩52.68 Million	-5.92%
2022	₩55.99 Million	-10.31%
2021	₩62.43 Million	-11.62%
2020	₩70.63 Million	+45.40%
2019	₩48.58 Million	+1.07%
2018	₩48.06 Million	+3.96%
2017	₩46.24 Million	+8.93%
2016	₩42.44 Million	+34.59%
2015	₩31.54 Million	--

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Korean Drug Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$24.94 Million USD
MoneyControl	$24.94 Million USD
MarketWatch	$24.94 Million USD
marketcap.company	$24.94 Million USD
Reuters	$24.94 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$24.94 Million

₩36.81 Billion KRW

Market Cap Rank

#24478 Global

#1752 in Korea

Share Price

₩3400.00

Change (1 day)

+0.74%

52-Week Range

₩3120.00 - ₩4630.00

All Time High

₩13030.58